Translating Aging
Translating Aging
XPRIZE Healthspan: Catalyzing Therapies for Aging (Jamie Justice, PhD)
Loading
/

XPRIZE Healthspan: Catalyzing Therapies for Aging (Jamie Justice, PhD)

Dr. Jamie Justice is Executive Director of the newly launched XPRIZE Healthspan, a $101 M international competition to accelerate therapeutics targeting aging biology. In conversation with host Chris Patil, Dr. Justice outlines the motivation, structure, and timeline of the prize, as well as how teams can get involved. She also explains unique aspects of this prize, including the public commentary period, how existing trials can be adapted for competition, functional endpoints, and judging criteria. She also conveys why coordination is needed to overcome barriers and drive investment in longevity R&D. Listeners will gain key insights into this ambitious initiative to catalyze progress translating research into treatments for aging.

Key ideas:

  • Why aging solutions need acceleration despite increased attention
  • The role and track record of incentive competitions like XPRIZE
  • Motivation and sponsors enabling XPRIZE Healthspan ($101M purse)
  • Timeline from conceptualization to upcoming 7-year active competition
  • Expert endpoint committee setting measurable functional criteria
  • Initial public commentary period for radical collaboration with teams
  • Phases: Intent to compete, qualifying submissions, finalist selection
  • Existing prevention trials can add program assessments
  • Common data and protocols to validate findings across teams
  • Goal of demonstrating restoration of function across domains
  • Secondary judging criteria around accessibility, biomarkers
  • Driving global coordination, investment, and innovation

Links:

XPRIZE Healthspan

Email questions, comments, and feedback to podcast@bioagelabs.com

Translating Aging on Twitter: @bioagepodcast

BioAge Labs Website bioagelabs.com

BioAge Labs Twitter @bioagelabs

BioAge Labs LinkedIn

More From Current Show

Matthew "Oki" O'Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new...
Listen Now
Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that...
Listen Now
Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe's most active longevity-focused venture capital...
Listen Now
In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay...
Listen Now
Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to...
Listen Now
Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with...
Listen Now
Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions...
Listen Now
Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life...
Listen Now

Related Episodes

No related episodes found.